The Board of Directors of Kobayashi Pharmaceutical Co., Ltd. has authorized a buyback plan on November 1, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5,601 JPY | +0.66% | +1.98% | -17.51% |
Mar. 31 | A second Kobayashi Pharma Japan factory inspected over deaths | RE |
Mar. 30 | Kobayashi factory searched over deaths possibly linked to supplements | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.51% | 2.66B | |
+14.17% | 396B | |
+12.76% | 143B | |
+18.42% | 77.23B | |
-12.61% | 65.65B | |
-10.33% | 48.32B | |
-7.57% | 39.2B | |
+7.11% | 35.21B | |
+11.84% | 18.31B | |
+14.87% | 15.95B |
- Stock Market
- Equities
- 4967 Stock
- News Kobayashi Pharmaceutical Co., Ltd.
- Kobayashi Pharmaceutical Co., Ltd. authorizes a Buyback Plan.